PCANTHE Stock Latest News
Private CompaniesAntheia Highlights $80 Million Conditional Loan Commitment and Scale-Up Progress4d agoANTHE
Private CompaniesAntheia Secures Conditional $80 Million Loan Commitment for Biomanufacturing Expansion1w agoANTHE
Private CompaniesAntheia Positions Biosynthesis Platform Amid U.S. Drug Supply Chain Concerns2w agoANTHE
Private CompaniesAntheia Highlights Role In Onshoring Advanced Pharma Supply Chains3w agoANTHE
Private CompaniesAntheia Highlights Global Engagement in Pharma Supply Chain and Biomanufacturing3w agoANTHEPrivate CompaniesAntheia Expands Global Industry Engagement With Pharma and Synthetic Biology Events1M agoANTHE
Private CompaniesAntheia Highlights AI-Driven Biomanufacturing Focus at Industry Conference1M agoANTHE- Private CompaniesAntheia Emphasizes Precision Analytics in Biosynthesis and Biomanufacturing1M agoANTHE
Private CompaniesAntheia Highlights Analytical Rigor in Biomanufacturing Approach2M agoANTHE
Private CompaniesAntheia Positioned in Policy-Focused Push for Domestic Biomanufacturing2M agoANTHE
Private CompaniesAntheia – Weekly Recap3M agoANTHEPrivate CompaniesFDA PreCheck Pilot Highlights Potential Tailwinds for U.S. Pharma Onshoring3M agoANTHE
Private CompaniesPublic Support for U.S. Biomanufacturing Highlights Onshoring Opportunity3M agoANTHE
Private CompaniesAntheia Highlights Leadership Expansion and Focus on Drug Supply Resilience3M agoANTHE- Private CompaniesAntheia Showcases Biosynthesis Platform to International Policy Delegation3M agoANTHE
- Private CompaniesAntheia Emphasizes Biomanufacturing Role in Securing Pharma Supply Chains3M agoANTHE
Private CompaniesAntheia Highlights Advanced Biosynthesis, Quality Expansion and Supply-Chain Strategy3M agoANTHEPrivate CompaniesAntheia Positions Advanced Biosynthesis as Solution to U.S. Drug Supply Vulnerabilities4M agoANTHE
Private CompaniesAntheia Expands Quality Leadership Amid Plans to Scale Commercial Operations4M agoANTHE